We are live on
!
Find out more
BI
BVF Inc Portfolio holdings
AUM
$3.14B
1-Year Est. Return
249.53%
This Fund
S&P 500
This Quarter
Est. Return
+56.08%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$2.97B
AUM Growth
+$504M
(+20%)
Cap. Flow
-$339M
Cap. Flow
% of AUM
-11.43%
Top 10 Holdings %
Top 10 Hldgs %
62.79%
Holding
48
New
2
Increased
8
Reduced
8
Closed
7
Top Buys
| 1 |
Xencor
XNCR
|
+$65.6M |
| 2 |
Disc Medicine
IRON
|
+$54.9M |
| 3 |
Invivyd
IVVD
|
+$40.6M |
| 4 |
Stoke Therapeutics
STOK
|
+$18.3M |
| 5 |
CBIO
Crescent Biopharma
CBIO
|
+$17.3M |
Top Sells
| 1 |
Protagonist Therapeutics
PTGX
|
+$170M |
| 2 |
CDTX
Cidara Therapeutics
CDTX
|
+$135M |
| 3 |
Axsome Therapeutics
AXSM
|
+$61.6M |
| 4 |
SEPN
Septerna Inc
SEPN
|
+$54.8M |
| 5 |
Revolution Medicines
RVMD
|
+$40.5M |
Sector Composition
| 1 | Healthcare | 99.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
4D Molecular Therapeutics
FDMT
$601M
| $34.7M | 1.17% |
4,629,289
| – | – |
|
|
CBIO
27
Crescent Biopharma
CBIO
$414M
| $32.6M | 1.1% |
2,748,763
+1,360,900
| +98% | +$17.3M |
|
28
Foghorn Therapeutics
FHTX
$308M
| $28.6M | 0.96% |
5,302,000
| – | – |
|
|
RPTX
29
DELISTED
Repare Therapeutics
RPTX
| $26.9M | 0.9% |
10,333,600
| – | – |
|
30
Avalo Therapeutics
AVTX
$968M
| $24.6M | 0.83% |
1,355,257
+1
| +0% | +$17 |
|
31
PepGen
PEPG
$176M
| $12.5M | 0.42% |
1,915,000
| – | – |
|
32
Eledon Pharmaceuticals
ELDN
$306M
| $9.5M | 0.32% |
6,293,282
| – | – |
|
33
X4 Pharmaceuticals
XFOR
$361M
| $8.93M | 0.3% |
2,233,742
| – | – |
|
|
34
Axsome Therapeutics
AXSM
$12.1B
| $8.36M | 0.28% |
45,757
-441,000
| -91% | -$61.6M |
|
|
MOLN
35
Molecular Partners
MOLN
$140M
| $5.82M | 0.2% |
1,353,968
| – | – |
|
|
IMA
36
ImageneBio Inc
IMA
$67.8M
| $5.53M | 0.19% |
802,102
| – | – |
|
37
TScan Therapeutics
TCRX
$60.8M
| $5.23M | 0.18% |
5,226,074
| – | – |
|
38
Tenax Therapeutics
TENX
$401M
| $4.14M | 0.14% |
339,549
| – | – |
|
39
Immunic
IMUX
$201M
| $4.08M | 0.14% |
765,297
| – | – |
|
|
IVA
40
Inventiva
IVA
$1.05B
| $3.19M | 0.11% |
686,040
| – | – |
|
41
enGene Therapeutics Warrants
ENGNW
$3.44M
| $2.4M | 0.08% |
945,402
| – | – |
|
|
CDTX
42
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-1,414,165
| Closed | -$135M |
|
43
Celcuity
CELC
$4.47B
| – | – |
-658,421
| Closed | -$32.5M |
|
|
EPIX
44
DELISTED
ESSA Pharma
EPIX
| – | – |
-11,668,473
| Closed | -$2.23M |
|
45
Forte Biosciences
FBRX
$880M
| – | – |
-65,350
| Closed | -$980K |
|
|
NCEL
46
NewcelX Ltd
NCEL
$20.6M
| – | – |
-14,368
| Closed | -$263K |
|
|
47
Protagonist Therapeutics
PTGX
$8.77B
| – | – |
-2,560,916
| Closed | -$170M |
|
48
SAB Biotherapeutics
SABS
$275M
| – | – |
-932,697
| Closed | -$1.87M |
|
Similar funds
GKWIM
BP
SC
AWE
EAM
HIMCH
SCM
AWM